PACB

Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Get 50% Off Elite

Peers: ILMN QSI TXG LAB TMO BRKR BNGO QGEN TWST SEER

| Held by: ARKE ARKK ARKG VTI IWM VXF IWO IBB VTWO SCHA

Scroll to Statements

Index	RUT
Market Cap	585.18M
Enterprise Value	1.09B
Income	-131.23M
Sales	161.39M
Book/sh	-0.20
Cash/sh	0.64
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	485
IPO	Oct 27, 2010

P/E	-
Forward P/E	-
PEG	-
P/S	3.63
P/B	-
P/C	2.93
P/FCF	-
EV/EBITDA	-
EV/Sales	6.76
Quick Ratio	3.72
Current Ratio	4.62
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-0.43
EPS next Y	-0.44
EPS next Q	-0.13
EPS this Y	76.01%
EPS next Y	-1.15%
EPS next 5Y	41.95%
EPS past 3/5Y	-9.18% -
Sales past 3/5Y	7.64% 15.19%
EPS Y/Y TTM	74.75%
Sales Y/Y TTM	4.41%
EPS Q/Q	3.72%
Sales Q/Q	5.52%
Earnings	Nov 04 AMC
EPS/Sales Surpr.	10.78% 3.19%

Insider Own	8.56%
Insider Trans	-2.51%
Inst Own	73.69%
Inst Trans	1.06%
ROA	-17.22%
ROE	-929.32%
ROIC	-20.44%
Gross Margin	32.52%
Oper. Margin	-98.09%
Profit Margin	-81.31%
SMA20	-18.15%
SMA50	-6.64%
SMA200	16.82%
Trades

Shs Outstand	312.24M
Shs Float	286.13M
Short Float	18.76%
Short Ratio	4.33
Short Interest	53.68M
52W High	3.43 -45.56%
52W Low	1.07 74.77%
Volatility	12.88% 12.88%
ATR (14)	0.28
RSI (14)	41.09
Beta	2.22
Rel Volume	0.56
Avg Volume	12.41M
Volume	3,500,985

Perf Week	-17.07%
Perf Month	-4.59%
Perf Quarter	54.55%
Perf Half Y	66.96%
Perf YTD	0.00%
Perf Year	14.72%
Perf 3Y	-70.96%
Perf 5Y	-93.16%
Perf 10Y	-76.51%
Recom	2.25
Target Price	2.74
Prev Close	1.97
Price	1.87
Change %	-5.08%

Consensus

Buy

Avg. Price Target

$2.74

Implied Upside

+46.5%

Analysts12incl. previous ratings

Rating Distribution6 Buy · 5 Hold · 1 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Sep 09, 2026	Resumed	UUBS	Neutral	$1.35	-27.8%
Mar 06, 2026	Downgrade	BBarclays	Equal Weight → Underweight	$1.50	-19.8%
Nov 11, 2024	Downgrade	UUBS	Buy → Neutral
Jun 03, 2024	Resumed	JJefferies	Buy	$4	+113.9%
Apr 22, 2024	Downgrade	JJP Morgan	Overweight → Neutral
Apr 18, 2024	Downgrade	GGoldman	Buy → Neutral	$7 → $2.50	+33.7%
Dec 14, 2023	Initiated	SStephens	Overweight	$11	+488.2%
Dec 14, 2023	Initiated	GGuggenheim	Neutral
Dec 13, 2023	Initiated	WWolfe Research	Peer Perform
Nov 17, 2023	Upgrade	UUBS	Neutral → Buy	$13 → $10	+434.8%
Oct 31, 2023	Upgrade	CCantor Fitzgerald	Neutral → Overweight	$11	+488.2%
Sep 28, 2023	Initiated	BBernstein	Outperform	$11	+488.2%
Jul 05, 2023	Resumed	JJP Morgan	Overweight	$13	+595.2%
Jun 30, 2023	Initiated	GGoldman	Buy	$17	+809.1%
May 10, 2023	Initiated	BBarclays	Equal Weight	$14	+648.7%
Mar 31, 2023	Upgrade	TTD Cowen	Market Perform → Outperform	$13 → $15	+702.1%
Feb 02, 2023	Initiated	UUBS	Neutral	$13	+595.2%
Jan 20, 2023	Downgrade	CCantor Fitzgerald	Overweight → Neutral	$12	+541.7%
Jan 05, 2023	Initiated	BScotiabank	Sector Outperform	$12	+541.7%
Jan 21, 2022	Resumed	CCantor Fitzgerald	Overweight	$62 → $31	+1,557.8%

Nov-04-26 07:13PM	PacBio Beats On Sequential Rebound And Deep Cost Cuts, But Another Guidance Trim And Margin Squeeze Keep The Inflection Story Unproven (Earnings Whispers)
05:24PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press)
04:05PM	PacBio Announces Third Quarter 2026 Financial Results (GlobeNewswire)
Oct-31-26 01:05AM	Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks But Pares Stake In This Pharma Giant That Had A Blowout Q3 (Stocktwits)
Oct-27-26 06:58PM	PacBio's SPARCnext Transition Faces Its First Real Test After Three Straight Guidance Cuts (Earnings Whispers) +8.89% +15.51%
04:05PM	Loading…
04:05PM	PacBio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-19-26 09:05AM	PacBio and Verily Health Announce Multi-Year Strategic Collaboration to Scale Long-Read Genomics for Biomedical AI (GlobeNewswire) +6.36%
Oct-14-26 04:05PM	PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026 (GlobeNewswire)
Oct-06-26 11:51AM	PacBio Sinks 8% as TychoBio Endorses Its Highest Quality Biological Data the Real Story Is More Complicated (TIKR) -5.92%
09:05AM	PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics (GlobeNewswire)
Oct-01-26 11:44AM	3 Biotech Stocks Put Traders Are Targeting Today (Schaeffer's Research) +5.91%
Sep-03-26 04:05PM	PacBio to Participate in the Morgan Stanley 24?? Annual Global Healthcare Conference (GlobeNewswire)
Aug-05-26 04:46PM	Pacific Biosciences: Q2 Earnings Snapshot (Associated Press) -9.72% -10.38%
04:08PM	PacBio Appoints Mark Van Oene as President and Chief Executive Officer (GlobeNewswire)
04:05PM	PacBio Announces Second Quarter 2026 Financial Results (GlobeNewswire)
09:05AM	Loading…
09:05AM	PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system (GlobeNewswire)
Jul-28-26 04:05PM	PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference (GlobeNewswire)
Jul-15-26 04:05PM	PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026 (GlobeNewswire)
Jun-15-26 02:48PM	Cathie Wood Buys $444 Million in SpaceX, Dumps Tesla and AMD (GuruFocus.com)
May-26-26 09:05AM	PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing (GlobeNewswire)
May-21-26 04:05PM	PacBio to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire) +5.04%
May-19-26 09:00AM	Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology (Business Wire)
May-11-26 09:05AM	HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss (GlobeNewswire)
May-07-26 04:33PM	Pacific Biosciences: Q1 Earnings Snapshot (Associated Press) -14.55%
04:05PM	PacBio Announces First Quarter 2026 Financial Results (GlobeNewswire)
Apr-21-26 09:05AM	PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing (GlobeNewswire)
Apr-16-26 04:05PM	PacBio to Report First Quarter 2026 Financial Results on May 7, 2026 (GlobeNewswire)
Apr-15-26 09:05AM	PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples (GlobeNewswire)
Mar-18-26 09:05AM	Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative (GlobeNewswire)
Mar-06-26 02:00PM	PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know (StockStory) -9.21%
09:14AM	Loading…
09:14AM	COO Declines Despite Q1 Earnings Beat and Raised FY26 Outlook (Zacks)
Mar-05-26 10:57AM	Clover Health Enters Collaboration to Be Part of CMS Aligned Network (Zacks)
10:56AM	Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now (Zacks)
08:30AM	PacBio Announces the Appointment of Chris Gibson to the Board of Directors (GlobeNewswire)
Mar-04-26 09:20AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
07:52AM	Intuitive Surgical Expands Direct Operational Presence in Europe (Zacks)
Mar-03-26 10:33PM	Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB) (StockStory) -6.17%
10:15AM	PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub (Zacks)
Feb-27-26 04:15PM	PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know (StockStory) -5.62%
Feb-25-26 11:50AM	TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates (Zacks)
Feb-24-26 03:10PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +5.06%
09:05AM	PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research (GlobeNewswire)
Feb-20-26 10:48AM	Genomics Stocks That Deserve a Place in Your Portfolio in 2026 (Zacks)
Feb-19-26 11:01PM	PacBio (PACB): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
12:35AM	5 Must-Read Analyst Questions From PacBio's Q4 Earnings Call (StockStory)
Feb-18-26 04:05PM	PacBio to Participate in the TD Cowen 46th Annual Health Care Conference (GlobeNewswire)
Feb-13-26 10:24AM	PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up (Zacks) -7.07%
08:21AM	PACB Q4 Deep Dive: Consumables and Clinical Adoption Drive Growth as SparkNex Launch Nears (StockStory)
12:03AM	Pacific Biosciences of California Inc (PACB) Q4 2025 Earnings Call Highlights: Strong Revenue ... (GuruFocus.com)
Feb-12-26 08:14PM	Pacific Biosciences of California Q4 Earnings Call Highlights (MarketBeat)
05:35PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
04:56PM	PacBio (NASDAQ:PACB) Reports Strong Q4 CY2025 (StockStory)
04:40PM	Pacific Biosciences: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
07:00AM	PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner (GlobeNewswire)
Feb-10-26 10:04PM	PacBio Earnings: What To Look For From PACB (StockStory)
Feb-02-26 09:05AM	PacBio Completes Sale of Short-Read Sequencing Assets (GlobeNewswire) -8.85%
Jan-30-26 06:15PM	Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market (Zacks)
Jan-27-26 04:05PM	PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 (GlobeNewswire) -7.39%
Jan-23-26 06:15PM	Pacific Biosciences of California (PACB) Stock Dips While Market Gains: Key Facts (Zacks)
Jan-16-26 06:15PM	Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know (Zacks) -5.96% +6.79%
Jan-15-26 10:35AM	PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research (Zacks)
Jan-12-26 09:15AM	PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases (GlobeNewswire)
09:05AM	PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC) (GlobeNewswire)
09:05AM	PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue (GlobeNewswire)
Jan-09-26 11:20AM	PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities (Zacks)
Jan-08-26 11:01PM	3 Reasons to Sell PACB and 1 Stock to Buy Instead (StockStory)
09:05AM	PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell (GlobeNewswire)
Jan-07-26 06:15PM	Pacific Biosciences of California (PACB) Gains As Market Dips: What You Should Know (Zacks)
12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio (Zacks)
Jan-06-26 07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks) +5.05%
Jan-05-26 12:23PM	ARK Invest Boosts Gene-Editing Bets While Cutting Consumer Tech Exposure (GuruFocus.com) +7.61%
Jan-02-26 11:01AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
08:00AM	Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24 (StockStory)
Dec-31-25 05:00PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +8.09%
06:26AM	Cathie Wood Doubles Down on Biotech as 2025 Ends, Offloads Rocket Lab (GuruFocus.com)
Dec-30-25 11:49PM	Barclays Analyst Is Bullish On Pacific Biosciences of California, Inc. (PACB) (Insider Monkey)
04:05PM	PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-29-25 12:51PM	TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock (GuruFocus.com)
Dec-03-25 03:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory)
Nov-28-25 09:05AM	PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-26-25 09:40AM	Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? (Zacks) -9.13%
Nov-24-25 01:00PM	PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know (StockStory) +12.61%
Nov-18-25 08:48AM	Top 3 Genomics Stocks to Consider for Your Portfolio (Zacks) +5.10%
Nov-13-25 04:05PM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) -6.32%
12:00PM	Pacific Biosciences (PACB) Upgraded to Buy: Here's Why (Zacks)
Nov-12-25 03:20PM	Why PacBio (PACB) Shares Are Getting Obliterated Today (StockStory) -6.45%
12:36AM	5 Revealing Analyst Questions From PacBio's Q3 Earnings Call (StockStory)
Nov-11-25 12:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory) +5.68%
Nov-10-25 10:35PM	Spotting Winners: PacBio (NASDAQ:PACB) And Life Sciences Tools & Services Stocks In Q3 (StockStory)
Nov-06-25 01:19PM	PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y (Zacks) -7.05%
12:33AM	PACB Q3 Deep Dive: Consumable Strength Offsets Instrument Headwinds, Clinical Expansion in Focus (StockStory)
Nov-05-25 06:30PM	Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:54PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
04:02PM	PacBio Announces Third Quarter 2025 Financial Results (GlobeNewswire)
09:05AM	HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes (GlobeNewswire)
Nov-04-25 09:15AM	Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks) -10.71%
09:05AM	PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gibson James R II	See Remarks	Oct 06 '26	Option Exercise	1.18	500,000	590,000	1,745,663	Oct 08 04:07 PM
Gibson James R II	See Remarks	Oct 06 '26	Sale	3.11	661,815	2,056,921	1,083,848	Oct 08 04:07 PM
Jim Gibson	Officer	Oct 06 '26	Proposed Sale	2.87	661,815	1,899,409		Oct 06 04:23 PM
Van Oene Mark	See Remarks	Aug 17 '26	Sale	1.13	26,911	30,409	2,705,853	Aug 18 08:17 PM
MARK VAN OENE	Officer	Aug 17 '26	Proposed Sale	1.13	26,911	30,512		Aug 17 04:08 PM
Gibson James R II	See Remarks	Apr 01 '26	Sale	1.37	88,185	120,813	1,245,663	Apr 03 04:05 PM
JAMES GIBSON	Officer	Apr 01 '26	Proposed Sale	1.37	88,185	120,778		Apr 01 05:17 PM
HENRY CHRISTIAN O	See Remarks	Mar 03 '26	Sale	1.51	12,497	18,920	3,581,813	Mar 04 05:55 PM
Van Oene Mark	See Remarks	Mar 03 '26	Sale	1.51	6,504	9,847	2,243,634	Mar 04 05:54 PM
Farmer Michele	See Remarks	Mar 03 '26	Sale	1.51	2,979	4,510	305,948	Mar 04 05:54 PM
MARK D. VAN OENE	Officer	Mar 03 '26	Proposed Sale	1.51	6,504	9,849		Mar 03 04:24 PM
CHRISTIAN HENRY	Officer	Mar 03 '26	Proposed Sale	1.51	12,497	18,924		Mar 03 04:20 PM
Van Oene Mark	See Remarks	Feb 17 '26	Sale	1.58	129,790	204,549	1,797,745	Feb 19 08:33 PM
Van Oene Mark	See Remarks	Feb 18 '26	Sale	1.63	55,107	89,769	1,742,638	Feb 19 08:33 PM
HENRY CHRISTIAN O	See Remarks	Feb 17 '26	Sale	1.58	331,793	522,906	2,814,374	Feb 19 08:31 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '26	Sale	1.63	140,874	229,484	2,673,500	Feb 19 08:31 PM
Farmer Michele	See Remarks	Feb 17 '26	Sale	1.58	35,215	55,499	234,044	Feb 19 08:28 PM
Farmer Michele	See Remarks	Feb 18 '26	Sale	1.63	14,952	24,357	219,092	Feb 19 08:28 PM
MARK VAN OENE	Officer	Feb 17 '26	Proposed Sale	1.58	303,739	478,693		Feb 17 06:27 PM
CHRISTIAN HENRY	Officer	Feb 17 '26	Proposed Sale	1.58	606,312	955,548		Feb 17 06:25 PM

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Co-FounderDr. Stephen Turner Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

All the Features.Half the Price.

Pacific Biosciences of California Inc

Upgrade your Finviz experience

All the Features.
Half the Price.